The Gross Margin of Isracann Biosciences Inc (IPOT.CN) is 20.92%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-05-31 | 20.92% |
2021-05-31 | 53.85% |
2020-05-31 | 20.92% |
2019-05-31 | -16.91% |